[Therapeutic Effects of Low-Dose Bevacizumab for the Treatment of Recurrent Brain Metastases].
Hattori E, Miyakoshi A, Go K, Aotake T, Kawakami Y, Sakamoto M, Kawauchi T, Oichi Y, Sano N, Hayase M, Ohta M, Hirose Y, Toda H.
Hattori E, et al. Among authors: go k.
No Shinkei Geka. 2018 Feb;46(2):107-115. doi: 10.11477/mf.1436203685.
No Shinkei Geka. 2018.
PMID: 29449515
Japanese.